Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment

Published:2015-02 Issue: Volume:71 Page:115-123
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Sinder Benjamin P.,Salemi Joseph D.,Ominsky Michael S.,Caird Michelle S.,Marini Joan C.,Kozloff Kenneth M.

Funder

NIH

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. New perspectives on osteogenesis imperfecta;Forlino;Nat Rev Endocrinol,2011

2. Osteogenesis imperfecta after the menopause;Paterson;N Engl J Med,1984

3. Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study;Sakkers;Lancet,2004

4. Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study;Gatti;J Bone Miner Res,2005

5. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement;Letocha;J Bone Miner Res,2005

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta;Calcified Tissue International;2024-09-04

2. Sclerostin antibody enhances implant osseointegration in bone with Col1a1 mutation;Bone;2024-09

3. Bone matrix properties in adults with osteogenesis imperfecta are not adversely affected by setrusumab—a sclerostin neutralizing antibody;Journal of Bone and Mineral Research;2024-07-10

4. Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives;Journal of Orthopaedic Translation;2024-07

5. New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review;Journal of Clinical Medicine;2024-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3